↓ Skip to main content

MicroRNAs in colorectal carcinoma - from pathogenesis to therapy

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, March 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
109 Dimensions

Readers on

mendeley
118 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNAs in colorectal carcinoma - from pathogenesis to therapy
Published in
Journal of Experimental & Clinical Cancer Research, March 2016
DOI 10.1186/s13046-016-0320-4
Pubmed ID
Authors

Yudan Chi, Dongming Zhou

Abstract

Acting as inflammatory mediators, tumor oncogenes or suppressors, microRNAs are involved in cell survival, death, epithelial-mesenchymal transition and metastasis, etc. Investigating the communication between microRNAs and tumorigenesis is critical to our understanding of the pathogenesis of multiple disease states. Currently, colorectal carcinoma (CRC), one of the most common malignancies worldwide, has a poor prognosis due to lack of an effective therapeutic option. Increasing evidence has identified altered profiles and regulatory potential of microRNAs in conditions related to environmentally-caused colorectal inflammation and colitis-associated cancer. Many studies have shed light on a more thorough understanding of the function and distribution of microRNAs in CRC initiation and emergence. However, the molecular mechanisms by which microRNAs modulate cellular processes still need to be further elucidated and may offer a foundation for evaluating microRNA-based therapeutic potential for CRC in both animal models and clinical trials. In this review, the roles and mechanisms of microRNAs involved in CRC from pathogenesis to therapy are summarized and discussed, which may provide more useful hints for CRC prevention and therapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 117 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 20%
Student > Ph. D. Student 18 15%
Researcher 16 14%
Student > Bachelor 13 11%
Student > Doctoral Student 12 10%
Other 16 14%
Unknown 19 16%
Readers by discipline Count As %
Medicine and Dentistry 31 26%
Biochemistry, Genetics and Molecular Biology 28 24%
Agricultural and Biological Sciences 14 12%
Immunology and Microbiology 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 10 8%
Unknown 25 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2016.
All research outputs
#19,944,994
of 25,374,647 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,462
of 2,378 outputs
Outputs of similar age
#218,229
of 314,783 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#17
of 32 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,378 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,783 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.